Please Wait.....
Report
North America Dry Eye Disease Market Forecast 2024-2032
Market Report I 2024-10-12 I 150 Pages I Inkwood Research
KEY FINDINGS
The North America dry eye disease market is expected to grow at a CAGR of 5.12% during the forecast period of 2024 to 2032. The market was valued at $2283.72 million in 2032, reaching a projected revenue of $3604.57 million by 2032.
MARKET INSIGHTS
The rising geriatric population in North America is a significant factor contributing to the growing number of cases of dry eye diseases. Older individuals are more prone to conditions affecting tear production, leading to common dry eye disease symptoms such as dryness, burning, and blurred vision. Environmental factors and lifestyle changes, including increased screen time, are also contributing to the increasing prevalence of dry eye disease across all age groups.
REGIONAL ANALYSIS
The North America dry eye disease market growth analysis includes a detailed examination of the United States and Canada. Technological advancements in therapeutic and diagnostic products are facilitating more effective treatment for dry eye disease. New dry eye disease treatment drugs and products, including artificial tears and anti-inflammatory medications, are improving patient outcomes. Moreover, the demand for dry eye disease treatment devices is on the rise, as these devices help enhance tear production and alleviate symptoms. Innovations in eye drops and treatment technologies are addressing the need for more efficient and targeted solutions.
In the United States, a National Health and Wellness Survey reports that 6.8% of the adult population is affected by dry eye disease, with prevalence increasing with age and being higher in females compared to males. Further analysis from the 2017 National Health and Wellness Survey (NHWS) indicates that the gender disparity in dry eye disease prevalence widens as age increases. Consequently, healthcare professionals expect a rise in cases of dry eye syndrome among the aging population.
Additionally, product launches and innovations by major companies are poised to boost market opportunities. For example, in 2022, Bausch + Lomb presented data from a second pivotal Phase 3 trial for their investigational treatment, NOV03. This would be the first pharmaceutical therapy in the United States featuring a new mechanism of action specifically targeting the relief of dry eye symptoms related to Meibomian gland dysfunction.
SEGMENTATION ANALYSIS
The North America dry eye disease market segmentation includes type, product, dosage, and distribution channel. The type segment is further classified into OTC and prescription.
Over-the-counter (OTC) treatments, including artificial tears and lubricating eye drops, are widely used products by patients for quick relief from dry eye disease symptoms. Leading players in this segment include Johnson & Johnson, which provides a variety of eye care products aimed at addressing dry eye symptoms. Companies such as Alcon and Allergan PLC also play a significant role in the OTC segment with their range of treatments for dry eye disease.
While the demand for anti-inflammatory drugs and treatment devices continues to rise, one of the challenges facing the market is the underdiagnosis of dry eye disease. Many patients remain unaware of their condition or do not seek proper treatment. However, increasing awareness through educational initiatives and improved access to diagnostic tools are expected to boost diagnosis rates, allowing for more effective management of the disease.
COMPETITIVE INSIGHTS
Some of the key firms operating in the North America dry eye disease market are Novartis AG, Novaliq GmbH, Lumenis, Oasis Medical, etc.
Oasis Medical Inc, headquartered in Los Angeles, California, is a specialized manufacturer of surgical supplies, instruments, disposables, and eye care products. The company produces a wide range of products aimed at treating retinal diseases, dry eye disease, refractive errors, and cataracts. One of its flagship products, Oasis TEARS PF PLUS Preservative-Free Lubricant Eye Drops, is designed to combat dry eye, offering viscoadaptive properties and strong adherence for effective relief.
TABLE OF CONTENTS
1. RESEARCH SCOPE & METHODOLOGY
1.1. STUDY OBJECTIVES
1.2. METHODOLOGY
1.3. ASSUMPTIONS & LIMITATIONS
2. EXECUTIVE SUMMARY
2.1. MARKET SIZE & ESTIMATES
2.2. MARKET OVERVIEW
2.3. SCOPE OF STUDY
2.4. CRISIS SCENARIO ANALYSIS
2.4.1. IMPACT OF COVID-19 ON THE DRY EYE DISEASE MARKET
2.5. MAJOR MARKET FINDINGS
2.5.1. PROLONGED SCREEN EXPOSURE CAN TRIGGER SYMPTOMS OF DRY EYE
2.5.2. INDIVIDUALS OF ASIAN DESCENT ARE MORE SUSCEPTIBLE TO DEVELOPING DRY EYE DISEASE
2.5.3. AIR POLLUTION IS A SIGNIFICANT CONTRIBUTOR TO EYE-RELATED CONDITIONS
2.5.4. THE COVID-19 PANDEMIC HAS LED TO A SURGE IN DRY EYE DISEASE CASES
3. MARKET DYNAMICS
3.1. KEY DRIVERS
3.1.1. RISING INCIDENCE AND PREVALENCE OF DRY EYE AMONG VARIOUS AGE GROUPS
3.1.2. LAUNCH OF PIPELINE PRODUCTS FOR THE TREATMENT OF DRY EYE DISEASE
3.1.3. INTRODUCTION OF NEW DIAGNOSTIC TECHNIQUES FOR DRY EYE DISEASE
3.2. KEY RESTRAINTS
3.2.1. RISK OF SIDE EFFECTS ASSOCIATED WITH TREATMENTS
3.2.2. AVAILABILITY OF ALTERNATIVE THERAPIES
3.2.3. HIGH COSTS OF SPECIALTY PRODUCTS AND A COMPLEX REIMBURSEMENT LANDSCAPE
4. KEY ANALYTICS
4.1. PARENT MARKET ANALYSIS
4.2. KEY MARKET TRENDS
4.2.1. EMERGING STEM CELL THERAPY IN THE TREATMENT OF DRY EYE DISEASE
4.3. PORTER'S FIVE FORCES ANALYSIS
4.3.1. BUYERS POWER
4.3.2. SUPPLIERS POWER
4.3.3. SUBSTITUTION
4.3.4. NEW ENTRANTS
4.3.5. INDUSTRY RIVALRY
4.4. GROWTH PROSPECT MAPPING
4.4.1. GROWTH PROSPECT MAPPING FOR NORTH AMERICA DRY EYE DISEASE MARKET
4.5. MARKET MATURITY ANALYSIS
4.6. MARKET CONCENTRATION ANALYSIS
4.7. VALUE CHAIN ANALYSIS
4.7.1. RESEARCH AND DEVELOPMENT
4.7.2. MANUFACTURING
4.7.3. DISTRIBUTORS
4.7.4. POST-SALES MONITORING
5. MARKET BY TYPE
5.1. OTC
5.2. PRESCRIPTION
6. MARKET BY PRODUCT
6.1. ANTI-INFLAMMATORY DRUGS
6.1.1. CYCLOSPORINE
6.1.2. CORTICOSTEROID
6.1.3. OTHER ANTI-INFLAMMATORY DRUGS
6.2. ARTIFICIAL TEARS
6.3. PUNCTAL PLUGS
6.4. SECRETAGOGUES
6.5. OTHER PRODUCTS
7. MARKET BY DOSAGE
7.1. EYE DROPS
7.2. EYE SOLUTIONS
7.3. OINTMENTS
7.4. GELS
7.5. CAPSULES & TABLETS
8. MARKET BY DISTRIBUTION CHANNEL
8.1. HOSPITAL PHARMACIES
8.2. INDEPENDENT PHARMACIES AND DRUG STORES
8.3. ONLINE PHARMACIES/STORES
9. GEOGRAPHICAL ANALYSIS
9.1. NORTH AMERICA
9.1.1. MARKET SIZE & ESTIMATES
9.1.2. NORTH AMERICA DRY EYE DISEASE MARKET DRIVERS
9.1.3. NORTH AMERICA DRY EYE DISEASE MARKET CHALLENGES
9.1.4. NORTH AMERICA DRY EYE DISEASE MARKET REGULATORY FRAMEWORK
9.1.5. KEY PLAYERS IN NORTH AMERICA DRY EYE DISEASE MARKET
9.1.6. COUNTRY ANALYSIS
9.1.6.1. UNITED STATES
9.1.6.1.1. UNITED STATES DRY EYE DISEASE MARKET SIZE & OPPORTUNITIES
9.1.6.2. CANADA
9.1.6.2.1. CANADA DRY EYE DISEASE MARKET SIZE & OPPORTUNITIES
10. COMPETITIVE LANDSCAPE
10.1. KEY STRATEGIC DEVELOPMENTS
10.1.1. MERGERS & ACQUISITIONS
10.1.2. PRODUCT LAUNCHES & DEVELOPMENTS
10.1.3. PARTNERSHIPS & AGREEMENTS
10.1.4. BUSINESS EXPANSIONS & DIVESTITURES
10.2. COMPANY PROFILES
10.2.1. ALCON
10.2.1.1. COMPANY OVERVIEW
10.2.1.2. PRODUCT LIST
10.2.1.3. STRENGTHS & CHALLENGES
10.2.2. ALLERGAN PLC (ACQUIRED BY ABBVIE)
10.2.2.1. COMPANY OVERVIEW
10.2.2.2. PRODUCT LIST
10.2.2.3. STRENGTHS & CHALLENGES
10.2.3. BAUSCH HEALTH COMPANIES INC
10.2.3.1. COMPANY OVERVIEW
10.2.3.2. PRODUCT LIST
10.2.3.3. STRENGTHS & CHALLENGES
10.2.4. JOHNSON & JOHNSON
10.2.4.1. COMPANY OVERVIEW
10.2.4.2. PRODUCT LIST
10.2.4.3. STRENGTHS & CHALLENGES
10.2.5. AFT PHARMACEUTICALS
10.2.5.1. COMPANY OVERVIEW
10.2.5.2. PRODUCT LIST
10.2.5.3. STRENGTHS & CHALLENGES
10.2.6. LUMENIS
10.2.6.1. COMPANY OVERVIEW
10.2.6.2. PRODUCT LIST
10.2.6.3. STRENGTHS & CHALLENGES
10.2.7. NOVALIQ GMBH
10.2.7.1. COMPANY OVERVIEW
10.2.7.2. PRODUCT LIST
10.2.7.3. STRENGTHS & CHALLENGES
10.2.8. OASIS MEDICAL
10.2.8.1. COMPANY OVERVIEW
10.2.8.2. PRODUCTS LIST
10.2.8.3. STRENGTHS & CHALLENGES
10.2.9. OTSUKA PHARMACEUTICAL CO LTD
10.2.9.1. COMPANY OVERVIEW
10.2.9.2. PRODUCT LIST
10.2.9.3. STRENGTHS & CHALLENGES
10.2.10. SANTEN PHARMACEUTICAL CO LTD
10.2.10.1. COMPANY OVERVIEW
10.2.10.2. PRODUCTS LIST
10.2.10.3. STRENGTHS & CHALLENGES
10.2.11. NOVARTIS AG
10.2.11.1. COMPANY OVERVIEW
10.2.11.2. PRODUCT LIST
10.2.11.3. STRENGTHS & CHALLENGES
10.2.12. SENTISS PHARMA PRIVATE LIMITED
10.2.12.1. COMPANY OVERVIEW
10.2.12.2. PRODUCTS LIST
10.2.12.3. STRENGTHS & CHALLENGES
10.2.13. TEVA PHARMACEUTICAL INDUSTRIES LTD
10.2.13.1. COMPANY OVERVIEW
10.2.13.2. PRODUCT LIST
10.2.13.3. STRENGTHS & CHALLENGES
10.2.14. SUN PHARMACEUTICAL INDUSTRIES LTD
10.2.14.1. COMPANY OVERVIEW
10.2.14.2. PRODUCT LIST
10.2.14.3. STRENGTHS & CHALLENGES
10.2.15. VISUFARMA
10.2.15.1. COMPANY OVERVIEW
10.2.15.2. PRODUCT LIST
10.2.15.3. STRENGTHS & CHALLENGES
LIST OF TABLES
TABLE 1: MARKET SNAPSHOT - DRY EYE DISEASE MARKET
TABLE 2: NORTH AMERICA DRY EYE DISEASE MARKET REGULATORY FRAMEWORK
TABLE 3: NORTH AMERICA DRY EYE DISEASE MARKET, BY TYPE, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 4: NORTH AMERICA DRY EYE DISEASE MARKET, BY TYPE, FORECAST YEARS, 2024-2032 (IN $ MILLION)
TABLE 5: NORTH AMERICA DRY EYE DISEASE MARKET, BY PRODUCT, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 6: NORTH AMERICA DRY EYE DISEASE MARKET, BY PRODUCT, FORECAST YEARS, 2024-2032 (IN $ MILLION)
TABLE 7: NORTH AMERICA DRY EYE DISEASE MARKET, BY ANTI-INFLAMMATORY DRUGS, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 8: NORTH AMERICA DRY EYE DISEASE MARKET, BY ANTI-INFLAMMATORY DRUGS, FORECAST YEARS, 2024-2032 (IN $ MILLION)
TABLE 9: NORTH AMERICA DRY EYE DISEASE MARKET, BY DOSAGE, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 10: NORTH AMERICA DRY EYE DISEASE MARKET, BY DOSAGE, FORECAST YEARS, 2024-2032 (IN $ MILLION)
TABLE 11: NORTH AMERICA DRY EYE DISEASE MARKET, BY DISTRIBUTION CHANNEL, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 12: NORTH AMERICA DRY EYE DISEASE MARKET, BY DISTRIBUTION CHANNEL, FORECAST YEARS, 2024-2032 (IN $ MILLION)
TABLE 13: NORTH AMERICA DRY EYE DISEASE MARKET, BY COUNTRY, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 14: NORTH AMERICA DRY EYE DISEASE MARKET, BY COUNTRY, FORECAST YEARS, 2024-2032 (IN $ MILLION)
TABLE 15: KEY PLAYERS OPERATING IN NORTH AMERICA DRY EYE DISEASE MARKET
TABLE 16: LIST OF MERGERS & ACQUISITIONS
TABLE 17: LIST OF PRODUCT LAUNCHES & DEVELOPMENTS
TABLE 18: LIST OF PARTNERSHIPS & AGREEMENTS
TABLE 19: LIST OF BUSINESS EXPANSIONS & DIVESTITURES
LIST OF FIGURES
FIGURE 1: KEY MARKET TRENDS
FIGURE 2: PORTER'S FIVE FORCES ANALYSIS
FIGURE 3: GROWTH PROSPECT MAPPING FOR NORTH AMERICA DRY EYE DISEASE MARKET
FIGURE 4: MARKET MATURITY ANALYSIS
FIGURE 5: MARKET CONCENTRATION ANALYSIS
FIGURE 6: VALUE CHAIN ANALYSIS
FIGURE 7: NORTH AMERICA DRY EYE DISEASE MARKET, GROWTH POTENTIAL, BY TYPE, IN 2023
FIGURE 8: NORTH AMERICA DRY EYE DISEASE MARKET, BY OTC, 2024-2032 (IN $ MILLION)
FIGURE 9: NORTH AMERICA DRY EYE DISEASE MARKET, BY PRESCRIPTION, 2024-2032 (IN $ MILLION)
FIGURE 10: NORTH AMERICA DRY EYE DISEASE MARKET, GROWTH POTENTIAL, BY PRODUCT, IN 2023
FIGURE 11: NORTH AMERICA DRY EYE DISEASE MARKET, BY ANTI-INFLAMMATORY DRUGS, 2024-2032 (IN $ MILLION)
FIGURE 12: NORTH AMERICA DRY EYE DISEASE MARKET, GROWTH POTENTIAL, BY ANTI-INFLAMMATORY DRUGS, IN 2023
FIGURE 13: NORTH AMERICA DRY EYE DISEASE MARKET, BY CYCLOSPORINE, 2024-2032 (IN $ MILLION)
FIGURE 14: NORTH AMERICA DRY EYE DISEASE MARKET, BY CORTICOSTEROID, 2024-2032 (IN $ MILLION)
FIGURE 15: NORTH AMERICA DRY EYE DISEASE MARKET, BY OTHER ANTI-INFLAMMATORY DRUGS, 2024-2032 (IN $ MILLION)
FIGURE 16: NORTH AMERICA DRY EYE DISEASE MARKET, BY ARTIFICIAL TEARS, 2024-2032 (IN $ MILLION)
FIGURE 17: NORTH AMERICA DRY EYE DISEASE MARKET, BY PUNCTAL PLUGS, 2024-2032 (IN $ MILLION)
FIGURE 18: NORTH AMERICA DRY EYE DISEASE MARKET, BY SECRETAGOGUES, 2024-2032 (IN $ MILLION)
FIGURE 19: NORTH AMERICA DRY EYE DISEASE MARKET, BY OTHER PRODUCTS, 2024-2032 (IN $ MILLION)
FIGURE 20: NORTH AMERICA DRY EYE DISEASE MARKET, GROWTH POTENTIAL, BY DOSAGE, IN 2023
FIGURE 21: NORTH AMERICA DRY EYE DISEASE MARKET, BY EYE DROPS, 2024-2032 (IN $ MILLION)
FIGURE 22: NORTH AMERICA DRY EYE DISEASE MARKET, BY EYE SOLUTIONS, 2024-2032 (IN $ MILLION)
FIGURE 23: NORTH AMERICA DRY EYE DISEASE MARKET, BY OINTMENTS, 2024-2032 (IN $ MILLION)
FIGURE 24: NORTH AMERICA DRY EYE DISEASE MARKET, BY GELS, 2024-2032 (IN $ MILLION)
FIGURE 25: NORTH AMERICA DRY EYE DISEASE MARKET, BY CAPSULES & TABLETS, 2024-2032 (IN $ MILLION)
FIGURE 26: NORTH AMERICA DRY EYE DISEASE MARKET, GROWTH POTENTIAL, BY DISTRIBUTION CHANNEL, IN 2023
FIGURE 27: NORTH AMERICA DRY EYE DISEASE MARKET, BY HOSPITAL PHARMACIES, 2024-2032 (IN $ MILLION)
FIGURE 28: NORTH AMERICA DRY EYE DISEASE MARKET, BY INDEPENDENT PHARMACIES AND DRUG STORES, 2024-2032 (IN $ MILLION)
FIGURE 29: NORTH AMERICA DRY EYE DISEASE MARKET, BY ONLINE PHARMACIES/STORES, 2024-2032 (IN $ MILLION)
FIGURE 30: NORTH AMERICA DRY EYE DISEASE MARKET, COUNTRY OUTLOOK, 2023 & 2032 (IN %)
FIGURE 31: UNITED STATES DRY EYE DISEASE MARKET, 2024-2032 (IN $ MILLION)
FIGURE 32: CANADA DRY EYE DISEASE MARKET, 2024-2032 (IN $ MILLION)
- Not Sure / Need Reassuring
- Confirm Content
-
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
-
- Sample Pages
-
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Check for Alternatives
-
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
-
- Confirm Content
- Prices / Formats / Delivery
- Prices
-
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Discounts
-
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Available Currencies
-
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
-
- Licenses
-
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Global Site License
-
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Formats
-
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
-
- Delivery
-
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
-
- Shipping Charges
-
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
-
- Prices
- Ordering
- By Credit Card
-
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
-
- By Money Transfer
-
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
-
- By Credit Card
- Security
- Website security
-
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
-
- Credit Card Security
-
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.
-
- Website security